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Spectrofluorimetry and Chemometrics for Investigation of
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Norfloxacin (NFX), a fluoroquinolone, was encapsulated in multi-
lamellar liposomes (MLV) of soy-bean phosphatidylcholine at pH
7.0. The observed affinity of this class of drugs for hydrophobic
environments, such as phospholipid bilayers, could lead to a better
understanding of the mechanism of uptake in bacteria. The fluo-
rescent properties of NFX were examined both free in solution and
in MLV, using anisotropy and fluorescence quenching measure-
ments. The latter data was treated with a chemometric method to
deconvolute the overlapped spectra of zwitterionic and neutral spe-
cies of NFX in equilibrium at this pH. The results show that NFX
incorporates into the lipidic bilayers with two different distributions
of species: the zwitterionic form in the lipid/aqueous interface, and
the neutral one, more towards the center of the bilayer.
Index Headings: Norfloxacin; Liposomes; Fluorescence; Chemome-
trics.
INTRODUCTION
Norfloxacin (NFX) is a partially hydrophobic fluoro-
quinolone antibiotic, which has a C-6 fluorine substituent
and a piperazine ring at position 7.1 These bactericidal
agents yield activity against a broad spectrum of both
Gram-positive and Gram-negative bacteria, inhibiting the
bacterial gyrase enzyme (Topoisomerase II), and are
highly effective in the treatment of a wide variety of in-
fectious diseases, mainly in the urinary tract and, more
recently, in the respiratory tract.2–4 NFX was synthesized
and registered in 1977 by Kyorin Pharmaceutical Co. (Ja-
pan) and was presented for therapeutic utilization in 1980
by Ito et al.5 However, only in 1987 was Norfloxacin
permitted to be used in the United States.5
An important feature of fluoroquinolones is their zwit-
terionic amphoteric nature. These molecules are ionized
over the whole pH range due to the presence of both
carboxylic and amino moieties (Fig. 1). These properties
may influence the distribution of the drug and its affinity
for lipid environments, particularly lipidic bilayers.6 This
characteristic is probably related to the phototoxic prop-
erties of NFX under solar ultraviolet (UV) radiation, such
as induction of dermic tumors in rats, phototoxicity in
mamarian cells in vitro, and7–9 accumulation in lysosomes
of HS68 human skin fibroblasts and other citoplasmatic
organelles, since fluoroquinolones are good photosensi-
tizers of reactive oxygen species.10,11
The entrapment of the fluoroquinolones in liposomes
could be of therapeutic interest. In fact, liposomal devices
might be capable of ensuring different pathways of in-
teraction with microbial cells, compared to the normal
routes followed by fluoroquinolones in entering cells.
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This behavior could be useful in the treatment of infec-
tions caused by quinolone-resistant bacteria or by mi-
crobes that are normally poorly sensitive to this class of
drugs.12 An investigation of the distribution of NFX in
liposomes would also help clarify the interaction of this
drug with biological membranes.
A liposomal formulation could increase drug concen-
tration at the site of infection due to the increased uptake
by the macrophages of the reticuloendotelial system and
half-lifetime, in addition to decreased systemic absorp-
tion, minimizing the side effects such as phototoxicity.13,14
In this way, these kinds of systems become more impor-
tant owing to their capacity to induce macrophage func-
tions and NO and cytokine production, which are nec-
essary in microbian, antineoplasic, and AIDS therapies.
This paper describes some results on research involv-
ing NFX distribution in lipidic bilayers of multi-lamellar
liposomes (MLV) at pH 7.0 using spectrofluorimetric
measurements, such as fluorescence quenching and fluo-
rescence anisotropy, combined with a chemometric meth-
od of analysis.
EXPERIMENTAL
Materials and Methods. Preparation of Liposomes.
The multilamellar liposomes containing Norfloxacin
(NFX-MLV) were prepared as follows. Soy-bean phos-
phatidylcholine (PC; Epikuron 200SH, 25 and 45 mg),
cholesterol (15 mg), and NFX (10.0 mmol) were dis-
solved in a mixture of chloroform and methanol (2:1,
v:v), and the solvents were removed by evaporation. The
lipid film was hydrated with 10.0 mL of 0.010 mol/L
HEPES buffer (pH 7.0) at 65 8C. The samples were cen-
trifuged at 6000 rpm for 20 min, and the liposomal pellet
was separated from the supernatant containing non-en-
capsulated drug. The liposomal pellet was resuspended
in buffer, mixed, and re-centrifuged two additional times.
Anisotropy Measurements. Steady-state measurements
of fluorescence anisotropy of free and liposomal NFX
(pH 7.0) were obtained on a Jobin Yvon-Spex Spectro-
fluorimeter (Fluorolog 3), with an accessory having L
geometry.
The theory of this technique is based on the excitation
and emission of polarized light. The polarization is a re-
sult of the so-called photoselection of fluorophores, ac-
cording to their orientation relative to the direction of the
polarized excitation. Nevertheless, the emission can be
depolarized by rotational diffusion, the most common
cause, which implies an angular displacement during the
lifetime of the excited state, in a way that the emitted
radiation does not show the same orientation as the ex-
citation one.
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FIG. 1. Chemical equilibria of different species of NFX as a function
of pH.
TABLE I. Fluorescence anisotropy values (r) for NFX and NFX-
MLV, at 25 8C in several solvents.
Solutions of NFX (1.0 3 1025 mol/L) r
Deionized water
HEPES buffer (pH 7)





MLV (45 mg PC, NFX 1.0 3 1024 mol/L)










Equation 1 was used to calculate the degree of fluo-
rescence anisotropy:
I 2 I\ ⊥r 5 (1)
I 1 2I\ ⊥
where I\ is the intensity measured through the polarizer
oriented parallel to the direction of the polarized excita-
tion, and I⊥ is the intensity through the perpendicular di-
rection. For a completely polarized light, r 5 1.
Fluorescence Quenching Studies. Fluorescence
quenching methods were applied to localize NFX in li-
pidic bilayers. All fluorimetric measurements were ob-
tained on an SLM-AMINCO Spectrofluorimeter (SPF-
500C), with a xenon lamp (250 W) as excitation source.
The excitation wavelength was 284 nm, and fluorescence
was monitored at 426 nm at a constant temperature. Free
and encapsulated NFX were incubated in quartz cells at
25 8C (below the phase transition temperature of Epiku-
ron, Tm ø 53 8C) in the presence of iodide (I2) and ac-
rylamide as quenching agents in 0.010 mol·dm23 HEPES
buffer (pH 7.0). All solutions contained 0.010 mol·dm23
sodium thiophosphate to prevent oxidation of the I2 ion,
avoiding I32 formation.15
Data were analyzed according to the Stern–Volmer
equation:
F0 5 1 1 K [Q] (2)DF
where F0 and F are the fluorescence intensities in the
absence and presence of the quencher Q, respectively,
and KD is the Stern–Volmer collision constant.
To distinguish between two populations of fluorop-
hores a treatment based on a modification of the Stern–
Volmer equation was used:16,17
F 1 10 5 1 (3)1 2[ ]DF f K [Q] fa D a
where f a is the fraction of the initial fluorescence that is
accessible to the quencher Q, DF is the difference be-
tween the fluorescence intensity in the absence (F0) and
presence (F) of quencher, and KD is the Stern–Volmer
constant.
To resolve the overlapped spectra and quenching pro-
files of the zwitterionic and neutral forms, the chemo-
metric method self-modeling curve resolution (SMCR),
developed by Lawton and Sylvestre (1971), was applied
in each experiment. This method uses a principal com-
ponents analysis (PCA), based on kernel singular value
decomposition (SVD).18 In this case, it allows spectral
deconvolution assuming the presence of only two sub-
stances. The SMCR method uses the following assump-
tions: (1) the curves must be non-negative; (2) the curves
in the data set must be a linear combination of two lin-
early independent curves; and (3) at least one wavelength
must exist for each substance where just that substances
fluoresces.19
The SMCR method was carried out on a matrix con-
structed of relative fluorescence spectra, F0/DF.
RESULTS AND DISCUSSION
Anisotropy measurements were worthwhile as a strong
indication of encapsulation. The results, listed in Table I,
allowed the observation of values directly related to the
kind of environment where the fluorophores were distrib-
uted. In hydrophobic environments, such as liposomal li-
pidic bilayers, higher values were noted, followed by val-
ues from micelles. This means that the molecules of the
drug penetrate into these two systems, causing a differ-
ence in their rotational diffusion, indicating a more re-
stricted degree of freedom in liposomal systems.
Free rotations in solution were related to the smallest
values of r, compared to the states cited above. However,
NFX showed a stronger interaction in ethanol and chlo-
roform than in aqueous solutions, decreasing their rota-
tional movements and increasing anisotropy values.
These results indicate that NFX molecules are inserted
deeply into the lipidic bilayer of MLV liposomes, and the
fluorescence quenching technique was used to obtain in-
formation on the localization of each specimen of NFX
in the lipidic environment according to the pH to better
understand the fluoroquinolone distribution in bacteria. In
neutral medium, there is equilibrium between the neutral
and zwitterionic forms of NFX, where the latter one pre-
dominates. It was expected that the neutral form would
be incorporated into the bilayer, while the zwitterionic
form would be in contact with the water/lipid interface.6,20
Fluorescence quenching studies were performed at pH
7 by using iodide and acrylamide as quenchers in free
and liposomal NFX solutions. The concentrations of both
quenchers were varied from 0 to 0.25 mol/L, a range in
which it has been shown that quencher concentrations
induce no changes in the lipid bilayer structure.16
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FIG. 2. (a, c) Resolved fluorescence spectra of zwitterionic (dashed line) and neutral forms (solid line) and (b, d) quenching fluorescence profiles
of zwitterionic (squares) and neutral forms (circles), quenched by iodide in (a, b) the absence and (c, d) the presence of liposomes.
Applying the chemometric method developed by Law-
ton and Sylvestre18 to the fluorescence spectral data, it
was possible to obtain the resolved fluorescence spectra
and the fluorescence quenching profiles of the neutral and
zwitterionic forms of NFX separately (Figs. 2 and 3).
However, the quenching constants were obtained from
the experimental spectra and not from the calculated
ones.
For each fluorescence quenching spectra the Stern–
Volmer equation (Eq. 2) was applied, which describes the
occurrence of dynamic and static quenching. The Stern–
Volmer plots of these samples deviated from linearity
with upward curvatures, suggesting the occurrence of
both static and dynamic quenching (data not shown). Dy-
namic quenching is a process whereby external environ-
mental influences (quenchers) interfere with the behavior
of the excited state after its formation. It modifies both
the emission intensity and the fluorescence lifetime. Oth-
erwise, in static quenching, the quencher inhibits excited
state formation, altering only the emission intensity.21 In
general, static and dynamic quenching can be distin-
guished by their different temperature dependences and
viscosities, or, preferably, by lifetime measurements.
A linear Stern–Volmer plot is generally indicative of a
single class of fluorophores, all equally accessible to the
quencher.17 The existence of two populations of fluoro-
phores (neutral and zwitterionic forms) in liposomes at
pH 7, which is in accordance with the partial hydropho-
bicity of NFX, allowed the use of the modified Stern–
Volmer equation (Eq. 3) to obtain the rate of collisional
encounters between the fluorophore and the quencher,
called Stern–Volmer constant values, listed in Table II.
Iodide can quench the fluorescence of the drug only
when the fluorophore is in hydrophilic regions. On the
other hand, acrylamide is a hydrophobic molecule and
can permeate into the bilayer. According to the modified
Stern–Volmer constant values listed in Table II, it is seen
that iodide quenches both forms of NFX when it is free
in solution. However, in MLV liposomes, only the zwit-
terionic form was accessible to the quencher, although at
a lower rate than that observed for the free form. The
neutral species was not quenched by iodide because it
was located deeper, near the center of the bilayer, since
no polar molecules concentrate in the region that has the
largest free volume.20 This lack of quenching is inter-
preted as the inability of the charged and hydrated iodide
to enter the nonpolar interior of the liposome, and also
due to the low sensitivity of the equipment in detecting
signals of small amounts of NFX inserted in the lipid
bilayer. Therefore, one can conclude that the drug is in-
corporated in the MLV bilayers.
Utilizing acrylamide as quencher, it was observed that,
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FIG. 3. (a, c) Resolved fluorescence spectra of zwitterionic (dashed line) and neutral forms (solid line) and (b, d) quenching fluorescence profiles
of zwitterionic (squares) and neutral forms (circles), quenched by acrylamide in (a, b) the absence and (c, d) the presence of liposomes.
TABLE II. Stern–Volmer constants (KD) obtained at pH 7.0 for
free and encapsulated NFX using iodide and acrylamide as quench-
ers.

























for the free drug in solution, the neutral form of NFX
showed better interaction with this quencher than the
zwitterionic form (Kzwit 5 2.01 and Kneut 5 3.32 L/mol).
Also, a blue shift can be observed for the neutral speci-
men in the spectrum. Probably, the fundamental state of
this species presents a smaller dipole moment than the
excited state one. Such a state is better stabilized when
interacting with acrylamide, which is a nonpolar mole-
cule, as mentioned. This interaction leads to a shift to
shorter wavelengths. In MLV liposomes, both zwitterion-
ic and neutral forms were quenched by acrylamide, with
the distribution analysis of each specimen being possible,
confirming the existence of two populations of fluorop-
hores (neutral and zwitterionic) in lipid bilayers of MLV
liposomes.22 The local insertion of acrylamide molecules
in the lipid bilayer changes the environment around the
fluorophore, increasing the interactions between the fluo-
rophore and the quencher molecules. In this way there is
an enlargement of the spectral emission for the neutral
specimen, which is the one that has a better affinity for
the acrylamide. The differences in the spectra recovered
from acrylamide quenching measurements in water and
lipid can also be attributed to the low sensitivity of the
equipment. The descending behavior of quenching pro-
files proves the existence of such species, free in solution
or inserted in the lipidic bilayers.
CONCLUSION
Anisotropy measurements give qualitative information
on the incorporation of NFX molecules into the lipidic
bilayers of liposomal vesicles. On the other hand, fluo-
rescence quenching studies associated with chemometric
methods reveal the existence of two predominate popu-
lations of NFX (neutral and zwitterionic forms) in multi-
lamellar liposomes at pH 7.0.
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The results showed that the zwitterionic form of NFX
was incorporated into the lipid/aqueous interface of the
liposomes, and the neutral form was located more toward
the center of the bilayers. Iodide ions can quench the
fluorescence of both forms of NFX in non-liposomal so-
lution, but it cannot quench the encapsulated neutral form
in the bilayer because these ions don’t have access to the
interior of the bilayers. On the other hand, acrylamide
can be inserted into the bilayer, reaching the neutral spe-
cies and therefore quenching its fluorescence emission.
Monteiro et al.6 suggested that both neutral and zwitter-
ionic species permeate through the lipidic bilayers pas-
sively, although it is not possible to know their exact
location. However, it should be emphasized that the neu-
tral and zwitterionic spectra in lipidic bilayers could be
better resolved, which was not observed due to the poor
resolution of the chemometric method used.
This work suggests that only the neutral species reach-
es the interior of the bilayers, although both forms are
present in the liposomes.
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